Vaxcyte Inc
PCVX
ISIN US92243G1085 / Valor 54991636
Vaxcyte Inc
UMushroom community rating:
About company
Vaxcyte Inc is a biotechnology company focused on developing vaccines to address infectious diseases. Their primary focus is on improving existing pneumococcal vaccines to combat invasive pneumococcal disease, which is associated with high case-fatality rates, antibiotic resistance, and meningitis. The company is currently working on developing a 31-valent pneumococcal conjugate vaccine candidate, VAX-31, following their VAX-24 vaccine. In addition to their pneumococcal vaccine franchise, Vaxcyte is also working on vaccine candidates targeting Group A Strep, periodontitis, and Shigella in preclinical development.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
11017 M
Market cap (USD)
519,292
Daily traded volume (Shares)
92.72 / 85.33
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
